This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Shanghaitech University. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Fabio Mammano: Innovator in Antibody Research
Introduction
Fabio Mammano is a distinguished inventor based in Padua, Italy. He is recognized for his significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins.
Latest Patents
Mammano holds a patent for a fully human antibody specifically inhibiting Connexin 26. This invention provides a recombinant immunoglobulin with the structure of scFv-Fc. The antibody is characterized by its ability to recognize Connexin 26 and inhibit its hemichannel activity. The invention utilizes a specific amino acid sequence from the extracellular region of Connexin 26 as an antigen, demonstrating its potential in treating Connexin mutation-associated diseases.
Career Highlights
Fabio Mammano is affiliated with ShanghaiTech University, where he continues to advance his research in antibody development. His work has garnered attention for its innovative approach to addressing genetic disorders linked to Connexin mutations.
Collaborations
Mammano collaborates with notable colleagues, including Zhihu Qu and Guang Yang, who contribute to his research endeavors.
Conclusion
Fabio Mammano's work in developing targeted antibodies represents a significant advancement in biotechnology. His innovative research holds promise for the treatment of diseases associated with Connexin mutations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile